A week-long course of inhaled beta-agonist or anticholinergic agent may reduce dyspnea during exercise in COPD
- PMID: 8769538
- DOI: 10.1378/chest.109.6.1666-a
A week-long course of inhaled beta-agonist or anticholinergic agent may reduce dyspnea during exercise in COPD
Comment on
-
Is an anticholinergic agent superior to a beta 2-agonist in improving dyspnea and exercise limitation in COPD?Chest. 1995 Sep;108(3):730-5. doi: 10.1378/chest.108.3.730. Chest. 1995. PMID: 7656624 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources